Keywords: ضد انعقاد خوراکی جدید; Atrial fibrillation; New oral anticoagulants; Apixaban; Drug monitoring;
مقالات ISI ضد انعقاد خوراکی جدید (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ضد انعقاد خوراکی جدید; Lupus anticoagulant; New oral anticoagulants; Antiphospholipid syndrome; Rivaroxaban; Dabigatran;
Keywords: ضد انعقاد خوراکی جدید; Anticoagulação; Novos anticoagulantes orais; Terapêutica antiagregante; Farmacologia; Anticoagulation; New Oral Anticoagulants; AntiâPlatelet therapy; Pharmacology;
Keywords: ضد انعقاد خوراکی جدید; Embolie pulmonaire; Ãpidémiologie; Diagnostic; Traitement; Anticoagulant; Nouveaux anticoagulants oraux; Pulmonary embolism; Epidemiology; Diagnosis; Treatment; Anticoagulants; New oral anticoagulants;
Keywords: ضد انعقاد خوراکی جدید; Hemostasis; Blood transfusion; New oral anticoagulants; Anticoagulation; Quality;
Keywords: ضد انعقاد خوراکی جدید; Atrial fibrillation; Cardioversion; New oral anticoagulants; Warfarin;
Keywords: ضد انعقاد خوراکی جدید; Multimorbidity; Atrial fibrillation; Anticoagulation; Warfarin; New oral anticoagulants; Polypharmacy; Bleeding risk;
Keywords: ضد انعقاد خوراکی جدید; Venous thromboembolism; Cancer; New oral anticoagulants; Therapy;
Keywords: ضد انعقاد خوراکی جدید; (AF); Atrial fibrillation; (NOAC); New oral anticoagulants; (SPC); Summary of product characteristics; (LC-MS/MS); Liquid chromatography-tandem mass spectrometry; (CrCl); Creatinine clearance; Apixaban concentration; Atrial fibrillation; LC-MS/MS; Anti-FX
Keywords: ضد انعقاد خوراکی جدید; New oral anticoagulants; Direct action anticoagulants; Atrial fibrillation; Stroke; Intracranial haemorrhageNuevos anticoagulantes orales; Anticoagulantes de acción directa; Fibrilación auricular; Ictus; Hemorragia intracraneal
Keywords: ضد انعقاد خوراکی جدید; Anticoagulant; Renal function; Dosing; Atrial fibrillation; Anticoagulante; Función renal; PosologÃa; Fibrilación auricular; AF; atrial fibrillation; CG; Cockcroft-Gault; CKD-EPI; Chronic Kidney Disease Epidemiology Collaboration; GFR; glomerular filtr
Keywords: ضد انعقاد خوراکی جدید; Bleeding; New oral anticoagulants; Rivaroxaban; Dabigatran; Apixaban; Meta-analysis;
Keywords: ضد انعقاد خوراکی جدید; Fibrilación auricular no valvular; Nuevos anticoagulantes orales; Anticoagulantes orales no antagonistas de la vitamina K; Anciano; Profilaxis tromboembólica en fibrilación auricular; Non-valvular atrial fibrilation; New oral anticoagulants; Non-vitami
Keywords: ضد انعقاد خوراکی جدید; Acute ischemic stroke; anticoagulants; new oral anticoagulants; acute stroke therapy; thrombolysis; tPA; intracerebral hemorrhage;
Keywords: ضد انعقاد خوراکی جدید; Atrial fibrillation; Stroke; Thromboembolism; Anticoagulation; Barriers; Warfarin; New oral anticoagulants
Keywords: ضد انعقاد خوراکی جدید; Venous thromboembolism; New oral anticoagulants; Vitamin K antagonists; Recurrent venous thromboembolism; Bleeding;
Keywords: ضد انعقاد خوراکی جدید; Atrial fibrillation; New oral anticoagulants; Chronic anticoagulation management;
Keywords: ضد انعقاد خوراکی جدید; Intracerebral hemorrhage; Warfarin; Oral anticoagulation; New oral anticoagulants;
Keywords: ضد انعقاد خوراکی جدید; Venous thromboembolism; Cancer; New oral anticoagulants; Apixaban; Dabigatran; Rivaroxaban; Edoxaban
Keywords: ضد انعقاد خوراکی جدید; Anticoagulation; New oral anticoagulants; Reversal; Safety; Bleeding; Hemorrhage;
Keywords: ضد انعقاد خوراکی جدید; Beriplex; Prothrombin complex concentrate; New oral anticoagulants; Anticoagulant reversal;
Keywords: ضد انعقاد خوراکی جدید; Venous thromboembolism; Bridge therapy; Switch therapy; Outpatient venous thromboembolism treatment; New oral anticoagulants;
Keywords: ضد انعقاد خوراکی جدید; New oral anticoagulants; Survey; Guidelines; Recommendation;
Keywords: ضد انعقاد خوراکی جدید; AF; atrial fibrillation; cW; continuous warfarin; dOAC; discontinued warfarin; LA; left atrium; NOAC; new oral anticoagulants; OAC; oral anticoagulation; RF; radiofrequency; VKA; vitamin K antagonists; Atrial fibrillation; Catheter ablation; Heparin; Oral
Keywords: ضد انعقاد خوراکی جدید; New oral anticoagulants; Trauma; Bleeding; Reversion; Prothrombin complex concentrateNuevos anticoagulantes orales; Trauma; Hemorragia; Reversión; Complejo concentrado de protrombina
Shiga toxin 2a binds antithrombin and heparin, but does not directly activate platelets
Keywords: ضد انعقاد خوراکی جدید; eHUS; Escherichia coli-induced hemolytic uremic syndrome; Stx; Shiga toxin; EHEC; Enterohemorrhagic Escherichia coli; AT; antithrombin; AKI; acute kidney injury; t-PA antigen; tissue plasminogen activator antigen; PAI-1; t-PA-plasminogen activator inhibit
Guidelines of the French Society of Otorhinolaryngology (SFORL). Managing epistaxis under coagulation disorder due to antithrombotic therapy
Keywords: ضد انعقاد خوراکی جدید; Epistaxis; Anticoagulants; Antiplatelet agents; New oral anticoagulants; Direct oral anticoagulants;
Fibrilación auricular y flúter auricular
Keywords: ضد انعقاد خوراکی جدید; Fibrilación auricular; Flúter auricular; Riesgo trombótico; Nuevos anticoagulantes orales; Ablación con radiofrecuencia; Atrial fibrillation; Atrial Flutter; Thrombotic risk; New oral anticoagulants; Ablation with radiofrequency;
Sex related differences in patients with acute venous thromboembolism treated with new oral anticoagulants. A meta-analysis of the interventional trials
Keywords: ضد انعقاد خوراکی جدید; Gender; Venous thromboembolism; New oral anticoagulants; Direct oral anticoagulants;
The Effect of Cardiopulmonary Bypass on Dabigatran Levels
Keywords: ضد انعقاد خوراکی جدید; dabigatran; cardiopulmonary bypass; cardiac surgery; coagulation; new oral anticoagulants;
Acceso a los anticoagulantes de acción directa en España
Keywords: ضد انعقاد خوراکی جدید; Nuevos anticoagulantes orales; Acceso; Sistema Nacional de Salud español; New oral anticoagulants; Access; Spanish National Health System;
New antithrombotic therapies and complementary and alternative medicine (CAM): Chartering into unknown territory
Keywords: ضد انعقاد خوراکی جدید; Complementary and alternative medicine; Oral anticoagulants; New oral anticoagulants; Antiplatelets; New antiplatelets; Antithrombotics;
Evaluating the Importance of Heterogeneity of Treatment Effect: Variation in Patient Utilities Can Influence Choice of the “Optimal” Oral Anticoagulant for Atrial Fibrillation
Keywords: ضد انعقاد خوراکی جدید; atrial fibrillation; benefit-harm assessment comparative effectiveness research; efficacy; health-related quality of life; heterogeneity; network meta-analysis; new oral anticoagulants;
Bilateral Lung Transplantation in a Patient Receiving Rivaroxaban Anticoagulation
Keywords: ضد انعقاد خوراکی جدید; lung transplantation; rivaroxaban; new oral anticoagulants; coagulapathy;
D-dimer and histamine in early stage bacteremia: A prospective controlled cohort study
Keywords: ضد انعقاد خوراکی جدید; CVC; central venous catheter; DIC; disseminated intravascular coagulation; ISTH; International Society on Thrombosis and Haemostasis; ICU; Intensive Care Unit; LMWH; low molecular weight heparin; NOAC; new oral anticoagulants; SSTI; skin and soft tissue i
Recomendaciones sobre profilaxis, diagnóstico y tratamiento de la enfermedad tromboembólica venosa en Atención Primaria. Resumen del Documento de consenso SEACV-SEMERGEN
Keywords: ضد انعقاد خوراکی جدید; Profilaxis; Anticoagulación; Enfermedad tromboembólica venosa; Trombosis venosa profunda; Embolia de pulmón; SÃndrome postrombótico; Heparina; Nuevos anticoagulantes orales; Prophylaxis; Anticoagulation; Venous thromboembolic disease; Deep venous thr
Syndrome des antiphospholides « séronégatif », syndrome catastrophique, nouveaux anticoagulants : enseignements d'une observation de prise en charge difficile
Keywords: ضد انعقاد خوراکی جدید; Syndrome des antiphospholipides; Syndrome catastrophique des antiphospholipides; Coagulation intravasculaire disséminée; Nouveaux anticoagulants oraux; Antiphospholipid syndrome; Catastrophic antiphospholipid syndrome; Disseminated intravascular coagula
¿Qué aportan los nuevos anticoagulantes en la prevención del tromboembolismo venoso y arterial?
Keywords: ضد انعقاد خوراکی جدید; Nuevos anticoagulantes orales; Dabigatran; Rivaroxabán; Apixabán; Edoxabán; Profilaxis enfermedad tromboembólica en cirugÃa ortopédica; Tratamiento y prevención recurrencias en la enfermedad tromboembólica venosa; Fibrilación auricular no valvula
Transition of Patients From Blinded Study Drug to Open-Label Anticoagulation : The ENGAGE AF–TIMI 48 Trial
Keywords: ضد انعقاد خوراکی جدید; anticoagulation; atrial fibrillation; edoxaban; factor Xa inhibitor; new oral anticoagulants; vitamin K antagonistAF, atrial fibrillation; factor Xa, activated factor X; INR, international normalized ratio; NOAC, new oral anticoagulant; SEE, systemic embo
Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy: The PREVAIL Trial
Keywords: ضد انعقاد خوراکی جدید; atrial fibrillation; left atrial appendage; stroke prevention; LAA; left atrial appendage; NOACs; new oral anticoagulants; NVAF; nonvalvular atrial fibrillation; SE; systemic embolism; TEE; transesophageal echocardiography;
European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Summary of the document prepared by the Czech Society of Cardiology1
Keywords: ضد انعقاد خوراکی جدید; Atrial fibrillation; New oral anticoagulants; Prevention of thromboembolic events;
Les nouveaux anticoagulants oraux directs : rôle du laboratoire d'hémostase
Keywords: ضد انعقاد خوراکی جدید; Anticoagulants oraux directs; tests d'hémostase; antagonisation; hémorragie; New oral anticoagulants; coagulation assays; reversal; bleeding;
New anticoagulants in the treatment of patients with cancer-associated venous thromboembolism
Keywords: ضد انعقاد خوراکی جدید; venous thromboembolism; cancer; treatment; new oral anticoagulants
NOACs for thromboprophylaxis in medical patients
Keywords: ضد انعقاد خوراکی جدید; venous thrombosis prevention; medical patients; new oral anticoagulants
New Oral Anticoagulants
Keywords: ضد انعقاد خوراکی جدید; New oral anticoagulants; Venous thromboembolism; Direct thrombin IIa inhibitor; Direct factor Xa inhibitor;
New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis
Keywords: ضد انعقاد خوراکی جدید; Anticlotting Agent; Antithrombotic; Comparison; Ulcer; ACS; acute coronary syndrome; AF; atrial fibrillation; CI; confidence interval; DVT; deep vein thrombosis; GIB; gastrointestinal bleeding; LMWH; low-molecular-weight heparin; NNH; number needed to har
Protocolo de diagnóstico y tratamiento de la enfermedad tromboembólica venosa
Keywords: ضد انعقاد خوراکی جدید; Tromboembolismo venoso; Trombosis venosa profunda; Embolismo pulmonar; Imagen TEV; Heparinas; Nuevos anticoagulantes orales; Venous thromboembolism; Deep vein thrombosis; Pulmonary embolism; VTE imaging; Heparins; New oral anticoagulants;
Nuevas evidencias en la prevención secundaria de la enfermedad tromboembólica venosa
Keywords: ضد انعقاد خوراکی جدید; Prevención secundaria; Recurrencia enfermedad tromboembólica; Factores de riesgo de enfermedad; tromboembólica venosa; Nuevos anticoagulantes orales; Trombosis venosa residual; DÃmero D; Secondary thromboprophylaxis; Venous thromboembolism recurrence;
Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: Pool-analysis of phase III randomized clinical trials
Keywords: ضد انعقاد خوراکی جدید; venous thromboembolism; prophylaxis; new oral anticoagulants; enoxaparin; major bleeding; orthopedic surgery;